Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham(University of Minnesota System), Rebecca Zash(Beth Israel Deaconess Medical Center), Mahsa Abassi(University of Minnesota Medical Center), Nicole Engen(Fairview Health Services), Lauren J MacKenzie(Fairview Health Services), Melanie R. Nicol(University of Minnesota), Matthew F Pullen(Fairview Health Services), Brian I. Rini(Vanderbilt University Medical Center), Glen Drobot(Fairview Health Services), David R. Boulware(University of Minnesota Medical Center), Lindsey Collins(University of Minnesota), Sylvain Lother(Fairview Health Services), Emily G. McDonald(McGill University), Ryan Zarychanski(CancerCare Manitoba), Dayna Solvason, Alanna A Nascene(Fairview Health Services), Cameron Meyer‐Mueller(University of Minnesota), Elizabeth C Okafor(Fairview Health Services), Todd C. Lee(McGill University Health Centre), Stephen Selinsky, Margaret L. Axelrod(Washington University in St. Louis), Sarah M Lofgren(Fairview Health Services), Katherine Huppler Hullsiek(University of Minnesota), Ingrid A. Mayer(Vanderbilt University), Katelyn A Pastick(Fairview Health Services), Douglas Krakower, Dylan MacKay(University of Manitoba), Caleb P Skipper(University of Minnesota Medical Center), Justin M. Balko(Vanderbilt University Medical Center), Darlisha A Williams(University of Minnesota), Stephen J. Dunlop(University of Minnesota), Ananta Bangdiwala(RTI International), Peter Li(Oregon Health & Science University), Andrew Balster
Cited by 128
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206
|Journal of Clinical Oncology|2008|907
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655